drugset
drugset / Trial / NCT00472004

Study Comparing 17B Estradiol/TMG CC 1mg Vs. Tibolone In Postmenopausal Women

NCT00472004 ↗

Phase 4 Completed 204 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a Phase IV prospective, randomized, open label, comparative, multicenter study in generally healthy postmenopausal women receiving Totelle (17B Estradiol/TMG CC (1mg)) and Livial (Tibolone).

Timeline

Start
2006-02
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator 17B-estradiol Unknown 1 mg —
Comparator Tibolone Other / unclassified 2.5 mg —
Comparator Trimegestone Small molecule 0.125 mg —

Indications

No indication recorded.